$21.84
▼ $-0.61
(-2.72%)
Vol 1.6M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.4B
ROE
-87.2%
Margin
-1687.1%
D/E
0.00
Beta
2.35
52W
$5–$25
Wall Street Consensus
20 analysts · Apr 20266
Strong Buy
13
Buy
1
Hold
0
Sell
0
Strong Sell
95.0%
Buy Rating
Price Chart
Similar Stocks
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
IRON
Disc Medicine Inc
$3.0B
KOD
Kodiak Sciences Inc
$1.7B
SRPT
Sarepta Therapeutics Inc
$2.3B
BCRX
BioCryst Pharmaceuticals Inc
$1.6B
GRAL
Grail Inc
$3.3B
RLAY
Relay Therapeutics Inc
$1.5B
MLYS
Mineralys Therapeutics Inc
$2.9B
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.57
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.57 | — | — |
| Dec 2025 | $-0.61 | $-0.76 | $-0.15 |
| Sep 2025 | $-0.59 | $-0.65 | $-0.06 |
| Jun 2025 | $-0.54 | $-0.50 | +$0.04 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -87.4% | -87.4% | -87.4% | -87.4% | -87.2% | -87.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1080.9% | -1687.1% | -1687.1% | -1687.1% | -1687.1% | -1687.1% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 12.13 | 12.13 | 12.13 | 12.13 | 8.90 | 8.90 |
Key Ratios
ROA (TTM)
-75.6%
P/S (TTM)
188.26
P/B
3.7
EPS (TTM)
$-2.95
CF/Share
$-1.77
52W High
$25.30
52W Low
$5.15
$5.15
52-Week Range
$25.30
How does IMNM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
IMNM valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
188.3
▲
1365%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
3.7
▲
49%
above
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
IMNM profitability vs Biotechnology peers
ROE
-87.2%
▼
30%
below
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-1687.1%
▼
488%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-75.6%
▼
62%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
IMNM financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.9
▲
100%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.4
▲
142%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
IMNM fundamentals radar
IMNM
Peer median
Industry
IMNM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio